Nebraska LB109 prohibits certain provisions in insurance policies and health plans related to clinician-administered drugs and changes provisions.
Nebraska LB109 amends insurance policies and health plans to prohibit insurers from refusing to authorize or pay for clinician-administered drugs, imposing coverage limitations, or requiring higher costs for drugs not dispensed by selected pharmacies. It also restricts pharmacy benefit managers from certain actions, such as prohibiting pharmacies from disclosing information, excluding pharmacies from specialty networks, and imposing excessive fees.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
Analyze for Free
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.